Leticia Peris

Title: Leticia Peris: Innovator in Tubulin Carboxypeptidase Research

Introduction

Leticia Peris is a prominent inventor based in Moirans, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of diseases associated with tubulin carboxypeptidases. Her innovative work has led to the development of methods and compositions that hold promise for addressing neurological and cardiovascular disorders.

Latest Patents

Leticia Peris holds a patent for "Methods and pharmaceutical compositions for treating tubulin carboxypeptidases associated diseases." This patent describes the use of chemical proteomics with a unique irreversible inhibitor to identify the major brain tubulin carboxypeptidase (TCP) as a complex of vasohibin-1 (VASH1) and the Small Vasohibin-Binding Protein (SVBP). The findings reveal that VASH1 and its homologue, vasohibin-2 (VASH2), exhibit specific carboxypeptidase activity on microtubules when complexed with SVBP. The research highlights the enzymatic activity of these complexes and their role in neuronal differentiation and migration.

Career Highlights

Throughout her career, Leticia has worked with esteemed organizations such as Les Laboratoires Servier and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing our understanding of tubulin carboxypeptidases and their implications in various diseases.

Collaborations

Leticia has collaborated with notable colleagues, including Annie Andrieux and Marie-José Moutin. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Leticia Peris is a trailblazer in the field of pharmaceutical research, with a focus on tubulin carboxypeptidases. Her groundbreaking patent and collaborative efforts underscore her commitment to advancing medical science and improving treatment options for complex diseases.